Next Article in Journal
Preventing Multimorbidity with Lifestyle Interventions in Sub-Saharan Africa: A New Challenge for Public Health in Low and Middle-Income Countries
Next Article in Special Issue
Characterizing the Landscape of Safety Net Programs and Policies in California during the COVID-19 Pandemic
Previous Article in Journal
A Narrative Literature Review of Bias in Collecting Patient Reported Outcomes Measures (PROMs)
Previous Article in Special Issue
Food Insecurity, Safety Nets, and Coping Strategies during the COVID-19 Pandemic: Multi-Country Evidence from Sub-Saharan Africa
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Rigorous Policy-Making Amid COVID-19 and Beyond: Literature Review and Critical Insights

Center on Smart and Connected Health Technologies, Mays Cancer Center, School of Nursing, UT Health San Antonio, San Antonio, TX 78229, USA
Int. J. Environ. Res. Public Health 2021, 18(23), 12447; https://doi.org/10.3390/ijerph182312447
Submission received: 10 October 2021 / Revised: 22 November 2021 / Accepted: 24 November 2021 / Published: 26 November 2021

Abstract

:
Policies shape society. Public health policies are of particular importance, as they often dictate matters in life and death. Accumulating evidence indicates that good-intentioned COVID-19 policies, such as shelter-in-place measures, can often result in unintended consequences among vulnerable populations such as nursing home residents and domestic violence victims. Thus, to shed light on the issue, this study aimed to identify policy-making processes that have the potential of developing policies that could induce optimal desirable outcomes with limited to no unintended consequences amid the pandemic and beyond. Methods: A literature review was conducted in PubMed, PsycINFO, and Scopus to answer the research question. To better structure the review and the subsequent analysis, theoretical frameworks such as the social ecological model were adopted to guide the process. Results: The findings suggested that: (1) people-centered; (2) artificial intelligence (AI)-powered; (3) data-driven, and (4) supervision-enhanced policy-making processes could help society develop policies that have the potential to yield desirable outcomes with limited unintended consequences. To leverage these strategies’ interconnectedness, the people-centered, AI-powered, data-driven, and supervision-enhanced (PADS) model of policy making was subsequently developed. Conclusions: The PADS model can develop policies that have the potential to induce optimal outcomes and limit or eliminate unintended consequences amid COVID-19 and beyond. Rather than serving as a definitive answer to problematic COVID-19 policy-making practices, the PADS model could be best understood as one of many promising frameworks that could bring the pandemic policy-making process more in line with the interests of societies at large; in other words, more cost-effectively, and consistently anti-COVID and pro-human.

1. Background

As much as policies shape society, they create it as well [1]. The change can be either slow or fast—depending on the context, newly found commonalities, communities, cultures, if not new reckonings among the civilizations, can either occur incrementally or with lightning speed [2,3,4]. Take COVID-19 prevention policies, for instance. Ranging from loose measures to long-term mandates, COVID-19 policies have created communities (e.g., mask supporters, anti-vaxxers, conspiracy theorists, and citizen vigilantes) [5,6,7], cultures (e.g., the xenophobic culture, the civic culture) [8,9,10], and perhaps most importantly, new understandings of the shared vulnerabilities and strengthens of the civilization (e.g., the peril of extremely tiny viruses, the power of small vials of vaccines, and the promise of victory-minded humanity) [11,12,13].
Public policies can be understood as the “purposive course of action followed by an actor or a set of actors in dealing with a problem or matter of concern” [14], which are often “formal, legally-binding measures adopted by legislative and administrative units of government” [15]. Overall, public policies are arbitrary rules and regulations developed to create social goods [16]. Ranging from shelter-in-place measures to lockdown mandates, and masking rules to vaccine regulations, one common denominator of these policies is their ability to curb the spread of the pandemic, and in turn, COVID-19 infections, hospitalizations, and deaths [17,18,19]. In an epidemiological modeling study across eight countries, researchers found that an additional delay of imposing lockdown measures amid COVID-19 outbreaks for one week could result in half a million deaths that could have been avoided [20]. In a similar vein, an early implementation of stringent public policies on physical distancing and an early lifting of these policies are the main reasons the state of California had successfully controlled the COVID-19 outbreak first [21], and only later became the first state in the U.S. that surpassed 500,000 confirmed cases and 10,000 deaths [22,23].
However, it is important to note that public policies could also result in unintended consequences. A growing body of research indicates that separating people from their familiar routines and social environments could have devastating effects on their physical and psychological health [24,25,26]. Furthermore, evidence indicates that COVID-19 physical distancing measures could cause mental disorders including distress, anxiety, depression, and suicidal behaviors [27,28,29]. This might be especially true among vulnerable populations—older adults, domestic violence victims, racial/sexual minorities, and other underserved communities were among those who have been shouldering the most pronounced adverse impacts across the pandemic [30,31,32,33].
Take nursing home residents, for instance. A key characteristic of nursing home residents is that they have either lost or are losing their abilities to take care of themselves, a situation that is particularly pronounced among those who suffer from cognitive impairments such as dementia [31]. Amid COVID-19, many nursing home residents were found to have been left for days without access to care, food, or water, let alone basic medicines, and many of them died during the abandonment [34]. While nursing homes are often plagued with various issues [35,36,37], elder abuse and neglect have rarely been this glaring prior to the pandemic [38,39]. One way to address these unintended consequences is via addressing their root cause—rather than scrambling to construct piecemeal policies at the eleventh hour, rigorously and pre-emptively developing policies, such as via evidence-based policy-making processes, may hold the key [40].
Evidence-based policy making can be understood as the law-making process that is guided by and developed on the basis of evidence [41]. A rich body of evidence suggests that evidence-based policy making can provide considerable benefits to society at large [42]. However, it is important to note that evidence-based policy making is not without flaws [43,44,45,46], many of which have either been highlighted or magnified amid the pandemic [47,48]. Conventional policy making often follows a range of one-directional steps, including agenda setting, policy formulation, policy adoption and application, and policy evaluation [49]. This means that in order for the resultant policies to be evidence-based, reflective of people’s needs, and have the potential to yield positive outcomes, the policy-making process is often thoroughly planned, detail-rich, time-consuming, and resource-dependent [50]—parameters that most of the pandemic-era policy-making might not be able to meet.
In other words, the unprecedented nature of the pandemic has effectively deprived policy makers of the time and planning needed to develop most conventional policies pre-emptively, let alone evidence-based ones that might be even more resource-demanding. Second, the fast-evolving characteristics of the pandemic led to the inevitability that, most, if not all, policies developed based on the conventional stage-oriented policy-making procedures would significantly lag reality. As seen amid the pandemic, “facts” and “truisms”, such as “evidence-based” predictions that claim that summer 2021 is when the pandemic would end, might sound naïve, if not juvenile, in light of the Delta-disturbed reality [51]. This means that policies that are developed on old evidence, even if it is one month old, may offer little to no utility to society at large. Third, due to a lack of clear understanding of and consensus on what could be classified as “evidence” [52], as seen amid COVID-19, oftentimes even anecdotal stories and personal opinions, if not gut feelings, have been enlisted as the “evidence” upon which policy makers alike based their pandemic policies [53].
These drawbacks, in turn, could significantly compromise public health policies’ abilities to produce much-needed positive effects on society with limited to no unintended consequences. In other words, the conventional evidence-based policy-making processes may not be able to develop policies amid COVID-19 that could:
(1)
yield desirable outcomes;
(2)
produce little to no unintended consequences in light of the unique challenges of the pandemic. However, there is a dearth of insights available in the literature that could address the above-mentioned issues. Thus, to bridge the research gap, this study aimed to identify policy-making processes that have the potential to develop policies that could induce optimal desirable outcomes with limited to no unintended consequences amid the pandemic and beyond.

2. Methods

A literature review was conducted in PubMed, PsycINFO, and Scopus to identify rigorous policy-making processes that could develop competent policies with the potential of producing desirable outcomes and curbing unintended consequences amid the unique challenges of the COVID-19 pandemic. Overall, the research question raised in the study had three interconnected components: rigorous policy-making processes that could (1) produce desirable pandemic prevention outcomes, with (2) limited to no unintended consequences, in light of the (3) unique challenges of COVID-19. In this study, desirable pandemic prevention outcomes can be understood as reduced COVID-19 infections, hospitalizations, and deaths. Whereas “adverse unintended consequences” and “unintended consequences” are used interchangeably, referring to negative policy outcomes that were different from expected results.
The search was developed based on two overarching concepts: COVID-19 and policy making. An example PubMed search term can be found in Table 1. All records reviewed were published in English. To effectively address this three-pronged research aim, the review strategy was developed based on three themes:
(1)
unique characteristics of COVID-19;
(2)
rigorous policy-making processes;
(3)
intended and unintended policy outcomes.
A set of eligibility criteria was adopted to screen the papers. Overall, articles were excluded if they:
(1)
did not focus on COVID-19;
(2)
did not center on the pandemic policy-making process;
(3)
did not provide insights into approaches that could either improve intended outcomes or avoid unintended consequences.
To ensure up-to-date insights were included in the analysis, validated news reports were also reviewed. Furthermore, Google Scholar alerts were set up so that relevant and most updated insights could be reviewed and analyzed to further shed light on the research question. The initial search was first conducted on 8 August 2021, with the subsequent one conducted on 15 October 2021, to include updated insights in the review.

3. Theoretical Underpinning

To better guide the review process and the subsequent analysis, theoretical insights from behavioral sciences were adopted as the guiding framework. Specifically, the theoretical underpinning of the study was grounded in the extensively documented understanding that behaviors could be both rational and irrational, as seen in the well-debated strengths and weaknesses of value-expectancy theories such as the Theory of Planned Behavior [54,55,56], for instance. In other words, the study investigated the research question via an empirically based understanding that, regardless of the scale and scope of the impacts of the actions, the policy-making process can be both rational and irrational. Furthermore, drawing insights from the Social Ecological Model [57], which posits that social behaviors are often shaped by a multitude of factors with divergent strengthens of influences that often manifest on varied levels of society, the study adopted a solution-focused mindset to address the research question—with difficulties galore, what can be done to improve the efficacy of pandemic policy making with substantially limited or eliminated unintended consequences?

4. Results

In terms of peer-reviewed research, a total of 28 papers were included in the final review (see Table 2). The findings of the review were organized in accordance with the research aim—identify rigorous policy-making processes that could produce positive outcomes with limited to no unintended consequences in light of the unique challenges and opportunities of the COVID-19 pandemic. It is important to underscore that only a limited number of studies have investigated COVID-19 policies from a procedural perspective (e.g., [58,59,60]). In other words, instead of examining COVID-19 policies from a connected and comprehensive perspective, most of the research has focused on nuanced aspects of COVID-19 policy making, ranging from concrete facilitators (e.g., more effective prediction or monitoring of virus spread) and tangible barriers (e.g., lack of quality data), to the promises of advanced technology-enabled decision aids (e.g., AI-based decision models) (e.g., [61,62,63,64]) that could either hinder the smoothness or success of the policy-making process. However, while these insights could not answer the research question directly, they nonetheless were important and could be useful to tackle the research aim.
Therefore, in light of the novelty of the research question and the dearth of research insights available in the literature, all relevant insights were thoroughly reviewed and analyzed. Overall, based on the literature review and the subsequent analysis, the result suggests that policy-making processes incorporating the following strategies could develop policies that have the potential of yielding desirable outcomes with limited unintended consequences:
(1)
people-centered: put people’s needs and wants at the center of the policy-making process, effectively prioritizing people over profits, politics, and the like [58,76,88,89,90,91,92,93];
(2)
artificial intelligence (AI)-powered: incorporating intelligent and automatic decision-making mechanisms to ensure the policies are developed based on the most updated evidence [83,94,95,96,97,98];
(3)
data-driven: the need to anchor key policy-making decisions with the support of empirical insights from quality data of optimal quantity and diversity [61,62,63,64,99,100,101,102];
(4)
supervision-enhanced: oversight mechanisms that scrutinize the behaviors of both the policy makers and the AI systems to further enhance policies’ abilities to produce positive outcomes without incurring unintended consequences [69,103,104,105,106,107,108].
To leverage these strategies’ interconnectedness, the people-centered, AI-powered, data-driven, and supervision-enhanced (PADS) model of policy making was subsequently developed. In the following section, the PADS model will be discussed in detail.

5. Discussion

This study aims to identify policy-making processes that have the potential to develop policies that could induce optimal desirable outcomes with limited to no unintended consequences amid COVID-19 and beyond. This is one of the first studies that investigated solutions that could shed light on the bevy of policy-making issues the COVID-19 pandemic has introduced or intensified, ranging from opaque and questionable policy-making processes and unquestioned and unchecked power of policymakers, to the unprecedented pace seen in the erosion of health equity and implosion of public dissent partially caused by unintended consequences of COVID-19 policies [109,110,111]. Aiming to address key issues in current policy-making practices—poor adoption of rigorous data analytics, lack of accountability, and oversized dependence on individual decision makers or policy makers, the study identified strategies that could establish and sustain the rigor in COVID-19 policy-making processes—the people-centered, AI-powered, data-driven, and supervision-enhanced (PADS) model of policy-making.

5.1. People-Centered

People-centered means to put people’s needs and wants at the center of the policy-making process, effectively prioritizing people over profits, politics, and the like [58,76,88,89,90,91,92,93]. It is important to note that “people” refers to all key stakeholders that are involved in the policy-making process, ranging from decision makers such as policy makers, decision supervisors such as independent experts, and decision benefactors such as the general public. Overall, it is important to underscore that the degree to which people agree with policies is a critical factor in shaping COVID-19 containment outcomes [112,113]. As the literature shows, how individuals adopt and comply with public policies, whether due to belief in science [114], economic concerns [115], political ideology [116], or perceived people-friendliness of the public policies (e.g., duration of the lockdown) [117], may influence the effectiveness of these policies in controlling the spread of COVID-19. In other words, public health policies, such as lockdowns, self-isolation, and spatial distancing measures are only effective if the public acts willingly in accordance with these measures [112,113,114,115,116,117].
By prioritizing the people’s collective interests over individual profits, partisan politics, or the dominant powers at the moment, the people-centeredness of the policy-making process or the PADS model could not only safeguard personal and public health, but also prompt better adherence to the resultant COVID-19 policies. Take China’s zero-COVID policy, for instance. The zero-COVID policy is a unique disease elimination/eradiation policy that has two pillars:
(1)
a “zero-tolerance” mindset that treats even single-digit positive COVID-19 cases or small disease outbreaks with the utmost urgency;
(2)
a “zero-delay” action plan that employs and deploys robust and rigorous collective and corroborative actions and measures to subdue positive cases and squash potential outbreaks.
Understandably, the zero-COVID policy and its use of mass quarantines and lockdowns are often considered draconian [118], particularly in light of the ever-loosening pandemic measures adopted by other societies [119,120]. However, as the policy is people-centered—developed factoring in the needs of all members of the society, including vulnerable communities such as older adults, frontline workers, and volunteers [67,121,122], and possibly future short-term residents such as participants of the Beijing 2022 Winter Olympic Games [123]—the zero-COVID policy remains well supported and rigorously followed by the public [93].

5.2. AI-Powered

AI can be understood as machine programs or algorithms that are “able to mimic human intelligence” [124]. The AI-powered component of the PADS model emphasizes the importance of incorporating intelligent and automatic decision-making mechanisms to ensure the policies are developed based on the most updated and comprehensive evidence robustly analyzed [83,94,95,96,97,98]. Advanced AI systems can help policymakers to make more informed policies that are both reactive (retrospectively analyzing data to develop intelligent solutions) and proactive (predictive decision-making insights based on advanced modelling) in nature [125,126,127]. Furthermore, AI systems can often serve as the essential platform that enables other advanced technologies, ranging from augmented reality and virtual reality to mixed reality, if not the metaverse. In addition to AI’s role as the enabler, it can also perform the function of enhancer—improving performance of everyday services or commonplace information and communication technologies [125,126,127].
For example, AI-based systems could help government and health officers develop algorithms that incorporate in-depth and comprehensive insights gained on big data analysis on diverse data in the policy-making process, ranging from search queries, medical records, public health records, social media posts, online purchases, and wastewater to surveillance footage [83,124]. The potential of AI systems can be further amplified when coupled with 5G or 6G technologies; 6G, the sixth-generation networking technologies, can be understood as the next-generation transmission technique following the 5G communication strategies [128,129,130,131,132,133,134,135] with enhanced key performance indicators (KPIs) and a wider range of real-world applications. Both 5G and 6G technologies can offer substantially greater computing powers to further improve an AI system’s abilities to generate empirical-based intelligence [128,129,130,131,132,133,134,135]. Research shows that, for instance, analyzing social media posts can offer a grounded and timely insight into citizens’ needs and wants, as well as concerns and considerations in times of crisis such as the COVID pandemic [136,137,138]. Emerging insights also suggest that even small local governments in the U.S. have integrated social media platforms, such as Facebook and Twitter, into their government functions [139], aiming to proactively incorporate public participation in the policy-making process.

5.3. Data-Driven

Data-driven entails the need to anchor key policy-making decisions upon the support of empirical evidence abstracted from quality data of great quantity and diversity [99,100,101,102]. Data-driven can refer to either big data analytics or data analyses based on smaller-scale databases. The importance of the data-driven element in the PADS model centers on the use and application of empirically gained insights, as opposed to subjective ideas, in the policy-making process. It is important to underscore that, thanks to advanced technologies such as 5G/6G and AI, a bevy of multifaceted information about public needs and preferences can be cost-effectively monitored, ranging from search queries, social media posts, and sewage data to medical records [83]. Having a diverse pool of heterogenous data paired with advanced computing powers provided by 5G/6G technologies and competent analytical skills enabled by AI means that government and health officials can gain a more complete and comprehensive understanding of the public’s perspective and sentiments towards key policy issues.
Data are, essentially, information about people. Depending on how the data were collected, they could either shed light on information on the people from a third-person perspective (e.g., surveillance footage), relevant information provided by the people via the lens of first-person perspective (e.g., digital diary), or information that is less reflective of differences in perspectives or transitory changes (e.g., biomedical data) [140]. In other words, the data-driven strategy could ensure that both the policy-making process and the resultant policies are founded on and reflective of the collective willpower from diverse perspectives. Overall, incorporating empirical evidence in the design, development, and delivery of policies to ensure the specific rules and regulations are in line with the general public’s needs and wants can be understood as a novel approach to public participation in policy making. Public participation can be understood as the involvement of the public in the government’s agenda-setting and decision-making processes [141]. Essentially, by incorporating big data about people, and oftentimes from people, the data-driven policy-making process constitutes a novel way of ensuring that the individual circumstances are sufficiently heard, considered, and reflected in the public policies, without demanding people’s physical presence in the policy-making process.

5.4. Supervision-Enhanced

To err is but human, and artificial intelligence is but a human creation. Noticeably, AI is intrinsically flawed in terms of its lack of ability to initiate ethical considerations and moral judgments [142,143]. In other words, regardless of how remarkable the AI-powered data analytical system might become, in light of the inherent flaws of AI systems—intelligent but without consciousness (e.g., ethical and moral considerations) [144,145,146]—it is essential to safeguard AI systems with instrumental human involvement, in the forms of both policy making by government and health officers and rigorous supervision by independent experts [106]. In other words, to effectively prevent AI from “augmenting disparities” [103] and fostering its abilities to address inequalities or accelerate integrity, sufficient supervision is needed.
Supervision can be understood as oversight mechanisms that scrutinize the behaviors of both the policy makers and the AI systems to further enhance the policies’ abilities to produce positive outcomes without incurring unintended consequences [69,103,104,105,106,107,108]. By rigorously leveraging the supervision-enhanced strategy, the PADS model could help society at large better limit or eliminate potential unintended consequences that could emerge in the policy development, deployment, or delivery processes. One way to form the supervision system is via incorporating an independent review board with rigorously vetted experts participating in the review board on a rotating basis. Other approaches, such as global collaboration [60,147], potentially paired with expertise from international health organizations such as the World Health Organization, may also work. Overall, in light of the multifaceted nature of the concept of “unintended consequences”, it is important to note that, while the presence and robustness of the supervision system are of utmost significance, having an “expert-review-needed” or supervision-needed mindset among policy makers is of equal importance.
One way to view unintended consequences is that they could either be a result of unplanned or unforeseen policy planning—”unplanned” refers to situations in which the negative outcomes are unintended but nonetheless not unanticipated [148], whereas “unforeseen” refers to scenarios in which policy makers were completely unaware of the potential unintended consequences. In other words, not all unintended consequences denote innocence and ignorance on the part of policy makers’—some policies might be made as a result of balancing pros and cons, which means that the welfare of some members of the society could be arbitrarily ignored or neglected during the policy-making process. These flaws could be reflected in AI systems as well [103], which could further compound the potential unintended consequences caused by the policies. A “supervision-needed” mindset could be the solution:
(1)
it could facilitate the establishment of policy-making practices that value the importance of supervision;
(2)
it could help policy makers avoid causing “unforeseen” consequences in the policy-making process;
(3)
it could help policy makers incorporate moral and ethical considerations, ranging from fairness, equality, and privacy to security concerns, in the policy-making process.

5.5. The Advantages of the PADS Model

In line with the principle of parsimony [149], the policy-making process could be simplified into two collaborative and non-collaborative processes [60,150]. A non-collaborative policy-making process often only involves policy makers. In other words, stakeholders’ input or feedback is often not involved in the process. On the other hand, the collaborative policy-making process not only involves the policy makers, but also stakeholders as well. As the process of policy making evolves, the degree of stakeholder involvement differs across contexts. However, regardless of how the collaboration takes place, this collaborative policy-making process nonetheless suffers from a key flaw—oftentimes both the policymakers and the stakeholders’ input are subjective. A schematic representation of these two policy-making approaches can be found in Figure 1.
Essentially, the leap from noncollaborative policy-making processes to collaborative policy-making processes only addresses one issue in the practice—the lack of public involvement in the decision-making process. In other words, though policies produced via the collaborative policy-making process might have greater abilities to address people’s needs and wants, they nonetheless could be flawed due to the highly subjective nature of the data upon which they are developed. One way to further improve the collaborative policy-making process is via replacing highly subjective and cross-sectional physical public participation with accumulated data that capture both the subjective and the objective needs and preferences of the stakeholders. In other words, data from the stakeholders (e.g., surveys), combined with data about the stakeholders (e.g., third-person perspective data such as surveillance footage, internet activities, etc.) and data about the overall situation from a multitude of perspectives, could serve as a considerably improved virtual proxy of public participation.
As evidence suggests, the general public may be well justified regarding whether or to what degree they wish to comply with COVID-19 public policies [112,113,114,115,116,117]. It is also worth noting that many, if not all, of the COVID-19 public policies were developed based on a top-down approach [151,152], and often without following the proper procedures that allow public participation in the policy-making process [153,154]. Though oftentimes public policy is held as a belief by some governments that “the governments decide to do or not to do” [155], as seen from COVID-19, for the greater good (e.g., achieve a post-pandemic reality), it should be considered and treated as a people-centered ecosystem that aims to serve the general public needs and preferences.
In other words, the data-driven component of PADS can effectively address issues that have been long plaguing policy-making: cross-sectional surveys about people’s needs and preferences are often flawed in offering stable and definitive insights about people, and longitudinal studies are often resource-dependent to conduct or limited in their abilities to provide timely insights into the subject matter. These insights combined suggest that the data-driven characteristics of the PADS model also share advantages that are commonly seen in general public participation in policy-making. It could:
(1)
better capture and comprehend the public’s needs and preferences;
(2)
design and develop public policies that are grounded in reality and people-centric; and in turn;
(3)
yield more desirable policy outcomes and limit potential unintended consequences [141,156,157,158,159].
An example of applying the PADS model for developing policies on the use and application of 5G and AI technologies in the context of aging-in-place can be found in Figure 2. Overall, Figure 2 illustrates how the people-centeredness of the PADS model respects and reflects key stakeholders’ needs and preferences in the policy-making process, with the aid of advanced technologies such as AI-powered systems and comprehensive supervision mechanisms.

5.6. Limitations

While this study bridged important research gaps, it was not without limitations. For starters, the review only focused on relevant articles published in the context of the COVID-19 pandemic. This means that potentially valuable insights that were not COVID-19-specific were not included in the review. Due to the focus of the study, challenges such as developmental hurdles associated with the use and application of AI were not discussed in detail in the study. Furthermore, due to the conceptual nature of the PADS model, no empirical evidence about its real-world efficacy is available at the moment. While the efficacies of public health policies could be difficult to evaluate [46], future studies could nonetheless explore innovative approaches to gauge the effectiveness of the PADS model in generating promising policies.

6. Conclusions

Policies can be the defining factor in shaping personal and public health, especially amid global catastrophes such as COVID-19. Amid the ever-increasingly chaotic jungle of COVID-19 policy making and the rapidly intensifying public expectations of greater accountabilities among policymakers, it is then vital to investigate rigorous policy-making strategies that could help societies at large develop more cost-effective COVID-19 policies. Based on insights gained from reviewing and analyzing the state-of-the-art evidence in the literature, this study developed the PADS model, which proposes a people-centered, AI-powered, data-driven, and supervision-enhanced approach towards policy making amid COVID-19. The PADS model can develop policies that have the potential to induce optimal outcomes and limit or eliminate unintended consequences amid COVID-19 and beyond. Rather than serving as a definitive answer to problematic COVID-19 policy-making practices, the PADS model can be best understood as one of many promising frameworks that could bring the pandemic policy-making process more in line with the interests of societies at large; in other words, more cost-effectively, and consistently anti-COVID and pro-human.

Funding

This research received no external funding.

Acknowledgments

The author wishes to express her gratitude to the editor and reviewers for their constructive input and insightful feedback.

Conflicts of Interest

The author declares no conflict of interest.

Abbreviations

COVID-19Coronavirus disease 2019
U.S.United States

References

  1. Skocpol, T.; Amenta, E. States and social policies. Annu. Rev. Sociol. 1986, 12, 131–157. [Google Scholar] [CrossRef]
  2. Burnside, C.; Dollar, D. Aid, Policies, and Growth. Am. Econ. Rev. 2000, 90, 847–868. [Google Scholar] [CrossRef] [Green Version]
  3. Von Solms, R.; von Solms, B. From policies to culture. Comput. Secur. 2004, 23, 275–279. [Google Scholar] [CrossRef]
  4. Eddy, D.M. Practice Policies: Where Do They Come From? JAMA 1990, 263, 1265. [Google Scholar] [CrossRef]
  5. Su, Z.; Wen, J.; Abbas, J.; McDonnell, D.; Cheshmehzangi, A.; Li, X.; Ahmad, J.; Šegalo, S.; Maestro, D.; Cai, Y. A race for a better understanding of COVID-19 vaccine non-adopters. Brain Behav. Immun. Health 2020, 9, 100159. [Google Scholar] [CrossRef]
  6. Grimes, D.R. Medical disinformation and the unviable nature of COVID-19 conspiracy theories. PLoS ONE 2021, 16, e0245900. [Google Scholar] [CrossRef] [PubMed]
  7. Shahsavari, S.; Holur, P.; Wang, T.; Tangherlini, T.R.; Roychowdhury, V. Conspiracy in the time of corona: Automatic detection of emerging COVID-19 conspiracy theories in social media and the news. J. Comput. Soc. Sci. 2020, 3, 279–317. [Google Scholar] [CrossRef]
  8. Noel, T.K. Conflating culture with COVID-19: Xenophobic repercussions of a global pandemic. Soc. Sci. Humanit. Open 2020, 2, 100044. [Google Scholar] [CrossRef]
  9. Su, Z.; McDonnell, D.; Ahmad, J.; Cheshmehzangi, A.; Li, X.; Meyer, K.; Cai, Y.; Yang, L.; Xiang, Y.T. Time to stop the use of ‘Wuhan virus’, ‘China virus’ or ‘Chinese virus’ across the scientific community. BMJ Glob. Health 2020, 5, e003746. [Google Scholar] [CrossRef]
  10. Durante, R.; Guiso, L.; Gulino, G. Asocial capital: Civic culture and social distancing during COVID-19. J. Public Econ. 2021, 194, 104342. [Google Scholar] [CrossRef]
  11. Su, Z.; McDonnell, D.; Cheshmehzangi, A.; Li, X.; Maestro, D.; Šegalo, S.; Ahmad, J.; Hao, X. With great hopes come great expectations: Access and adoption issues associated with COVID-19 vaccines. JMIR Public Health Surveill. 2021, 7, e26111. [Google Scholar] [CrossRef]
  12. Johns Hopkins University. Mortality Analyses. 2021. Available online: https://coronavirus.jhu.edu/data/mortality (accessed on 16 November 2021).
  13. Our World in Data. Coronavirus Pandemic (COVID-19). 2021. Available online: https://ourworldindata.org/coronavirus (accessed on 8 November 2021).
  14. Anderson, J.E. Public Policy-Making, 3rd ed.; Houghton Mifflin: Boston, MA, USA, 1984. [Google Scholar]
  15. Chriqui, J.F. Obesity Prevention Policies in U.S. States and Localities: Lessons from the Field. Curr. Obes. Rep. 2013, 2, 200–210. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Howlett, M. Designing Public Policies: Principles and Instruments; Routledge: London, UK, 2019. [Google Scholar]
  17. Lu, G.; Razum, O.; Jahn, A.; Zhang, Y.; Sutton, B.; Sridhar, D.; Ariyoshi, K.; von Seidlein, L.; Müller, O. COVID-19 in Germany and China: Mitigation versus elimination strategy. Glob. Health Action 2021, 14, 1875601. [Google Scholar] [CrossRef]
  18. Howard, J.; Huang, A.; Li, Z.; Tufekci, Z.; Zdimal, V.; van der Westhuizen, H.-M.; von Delft, A.; Price, A.; Fridman, L.; Tang, L.-H.; et al. An evidence review of face masks against COVID-19. Proc. Natl. Acad. Sci. USA 2021, 118, 2014564118. [Google Scholar] [CrossRef]
  19. Fu, Y.; Jin, H.; Xiang, H.; Wang, N. Optimal lockdown policy for vaccination during COVID-19 pandemic. Financ. Res. Lett. 2021, 102123. [Google Scholar] [CrossRef]
  20. Balmford, B.; Annan, J.D.; Hargreaves, J.C.; Altoè, M.; Bateman, I.J. Cross-Country Comparisons of COVID-19: Policy, Politics and the Price of Life. Environ. Resour. Econ. 2020, 76, 525–551. [Google Scholar] [CrossRef] [PubMed]
  21. The Economist. America Is in the Midst of an Extraordinary Surge of COVID-19. 2020. Available online: https://www.economist.com/united-states/2020/07/18/america-is-in-the-midst-of-an-extraordinary-surge-of-covid-19 (accessed on 11 August 2020).
  22. Yu, X.; Ansari, T. Coronavirus Latest: California Is First State to Pass 500,000 Infections. 2020. Available online: https://www.wsj.com/articles/coronavirus-latest-news-08-01-2020-11596268447 (accessed on 11 August 2020).
  23. Hawkins, D.; Iati, M. Coronavirus Update: California Surpasses 10,000 Deaths as Trump Signs Economic Relief Orders. 2020. Available online: https://www.washingtonpost.com/nation/2020/08/08/coronavirus-covid-updates/ (accessed on 11 August 2020).
  24. Sibley, C.G.; Greaves, L.M.; Satherley, N.; Wilson, M.S.; Overall, N.C.; Lee, C.H.J.; Milojev, P.; Bulbulia, J.; Osborne, D.; Milfont, T.L.; et al. Effects of the COVID-19 pandemic and nationwide lockdown on trust, attitudes toward government, and well-being. Am. Psychol. 2020, 75, 618–630. [Google Scholar] [CrossRef] [PubMed]
  25. Galea, S.; Merchant, R.M.; Lurie, N. The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention. JAMA Intern. Med. 2020, 180, 817–818. [Google Scholar] [CrossRef] [Green Version]
  26. Verbeek, H.; Gerritsen, D.L.; Backhaus, R.; de Boer, B.S.; Koopmans, R.T.; Hamers, J.P. Allowing Visitors Back in the Nursing Home During the COVID-19 Crisis: A Dutch National Study Into First Experiences and Impact on Well-Being. J. Am. Med Dir. Assoc. 2020, 21, 900–904. [Google Scholar] [CrossRef]
  27. Brown, E.; Gray, R.; Monaco, S.L.; O’Donoghue, B.; Nelson, B.; Thompson, A.; Francey, S.; McGorry, P. The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research. Schizophr. Res. 2020, 222, 79–87. [Google Scholar] [CrossRef] [PubMed]
  28. Mazza, C.; Ricci, E.; Biondi, S.; Colasanti, M.; Ferracuti, S.; Napoli, C.; Roma, P. A Nationwide Survey of Psychological Distress among Italian People during the COVID-19 Pandemic: Immediate Psychological Responses and Associated Factors. Int. J. Environ. Res. Public Health 2020, 17, 3165. [Google Scholar] [CrossRef]
  29. Guo, Q.; Zheng, Y.; Shi, J.; Wang, J.; Li, G.; Li, C.; Fromson, J.A.; Xu, Y.; Liu, X.; Xu, H.; et al. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study. Brain Behav. Immun. 2020, 88, 17–27. [Google Scholar] [CrossRef] [PubMed]
  30. Su, Z.; Cheshmehzangi, A.; McDonnell, D.; Šegalo, S.; Ahmad, J.; Bennett, B. Gender inequality and health disparity amid COVID-19. Nurs. Outlook 2021. [Google Scholar] [CrossRef]
  31. Su, Z.; McDonnell, D.; Li, Y. Why is COVID-19 more deadly to nursing home residents? QJM Int. J. Med. 2021, 114, 543–547. [Google Scholar] [CrossRef]
  32. Su, Z.; McDonnell, D.; Roth, S.; Li, Q.; Šegalo, S.; Shi, F.; Wagers, S. Mental health solutions for domestic violence victims amid COVID-19: A review of the literature. Glob. Health 2021, 17, 1–11. [Google Scholar] [CrossRef]
  33. Su, Z.; McDonnell, D.; Wen, J.; Kozak, M.; Abbas, J.; Šegalo, S.; Li, X.; Ahmad, J.; Cheshmehzangi, A.; Cai, Y.; et al. Mental health consequences of COVID-19 media coverage: The need for effective crisis communication practices. Glob. Health 2021, 17, 1–8. [Google Scholar] [CrossRef] [PubMed]
  34. Amnesty International. UK: Older People in Care Homes Abandoned to Die Amid Government Failures During COVID-19 Pandemic. 2021. Available online: https://www.amnesty.org/en/latest/press-release/2020/10/uk-older-people-in-care-homes-abandoned-to-die-amid-government-failures-during-covid-19-pandemic/ (accessed on 16 November 2021).
  35. Wang, F.; Meng, L.-R.; Zhang, Q.; Li, L.; Nogueira, B.O.L.; Ng, C.H.; Ungvari, G.S.; Hou, C.-L.; Liu, L.; Zhao, W.; et al. Elder abuse and its impact on quality of life in nursing homes in China. Arch. Gerontol. Geriatr. 2018, 78, 155–159. [Google Scholar] [CrossRef] [PubMed]
  36. Myhre, J.; Saga, S.; Malmedal, W.; Ostaszkiewicz, J.; Nakrem, S. Elder abuse and neglect: An overlooked patient safety issue. A focus group study of nursing home leaders’ perceptions of elder abuse and neglect. BMC Health Serv. Res. 2020, 20, 199. [Google Scholar] [CrossRef]
  37. Arens, O.B.; Fierz, K.; Zúñiga, F. Elder Abuse in Nursing Homes: Do Special Care Units Make a Difference? A Secondary Data Analysis of the Swiss Nursing Homes Human Resources Project. Gerontology 2016, 63, 169–179. [Google Scholar] [CrossRef]
  38. Abbasi, J. “Abandoned” Nursing Homes Continue to Face Critical Supply and Staff Shortages as COVID-19 Toll Has Mounted. JAMA 2020, 324, 123–125. [Google Scholar] [CrossRef]
  39. Makaroun, L.K.; Bachrach, R.L.; Rosland, A.-M. Elder Abuse in the Time of COVID-19—Increased Risks for Older Adults and Their Caregivers. Am. J. Geriatr. Psychiatry 2020, 28, 876–880. [Google Scholar] [CrossRef]
  40. Sanderson, I. Evaluation, Policy Learning and Evidence-Based Policy Making. Public Adm. 2002, 80, 1–22. [Google Scholar] [CrossRef]
  41. Banks, G. Evidence-Based Policy Making: What Is It? How Do We Get It? In World Scientific Reference on Asia-Pacific Trade Policies; World Scientific: Singapore, 2018; pp. 719–736. [Google Scholar]
  42. Richards, G.W. How Research–Policy Partnerships Can Benefit Government: A Win–Win for Evidence-Based Policy-Making. Can. Public Policy 2017, 43, 165–170. [Google Scholar] [CrossRef] [Green Version]
  43. Kemm, J. The limitations of ‘evidence-based’ public health. J. Eval. Clin. Pract. 2006, 12, 319–324. [Google Scholar] [CrossRef]
  44. Foti, K.; Foraker, R.E.; Martyn-Nemeth, P.; Anderson, C.A.; Cook, N.R.; Lichtenstein, A.H.; de Ferranti, S.D.; Young, D.R.; Hivert, M.-F.; Ross, R.; et al. Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials. Circ. Cardiovasc. Qual. Outcomes 2020, 13, 006378. [Google Scholar] [CrossRef] [PubMed]
  45. Sanderson, I. Making sense of ‘what works’: Evidence based policy making as instrumental rationality? Public Policy Adm. 2002, 17, 61–75. [Google Scholar] [CrossRef]
  46. Whittington, D.; Radin, M.; Jeuland, M. Evidence-based policy analysis? The strange case of the randomized controlled trials of community-led total sanitation. Oxf. Rev. Econ. Policy 2020, 36, 191–221. [Google Scholar] [CrossRef]
  47. Mazey, S.; Richardson, J. Lesson-Drawing from New Zealand and COVID-19: The Need for Anticipatory Policy Making. Polit. Q. 2020, 91, 561–570. [Google Scholar] [CrossRef] [PubMed]
  48. Ngqangashe, Y.; Heenan, M.; Pescud, M. Regulating Alcohol: Strategies Used by Actors to Influence COVID-19 Related Alcohol Bans in South Africa. Int. J. Environ. Res. Public Health 2021, 18, 11494. [Google Scholar] [CrossRef]
  49. Sabatier, P.A.; Weible, C. Theories of the Policy Process, 1st ed.; Westview Press: Boulder, CO, USA, 1999. [Google Scholar]
  50. Stoker, G.; Evans, M. (Eds.) Evidence-Based Policy Making in the Social Sciences; Penguin: London, UK, 2016. [Google Scholar]
  51. Wallace-Wells, B. What Happened to Joe Biden’s “Summer of Freedom” from the Pandemic? 2021. Available online: https://www.newyorker.com/news/annals-of-inquiry/what-happened-to-joe-bidens-summer-of-freedom-from-the-pandemic (accessed on 8 November 2021).
  52. Phillips, P.W.; Castle, D.; Smyth, S.J. Evidence-based policy making: Determining what is evidence. Heliyon 2020, 6, e04519. [Google Scholar] [CrossRef]
  53. Evanega, S.; Lynas, M.; Adams, J.; Smolenyak, K.; Insights, C.G. Coronavirus Misinformation: Quantifying Sources and Themes in the COVID-19 ‘Infodemic’; Cornell University: Ithaca, NY, USA, 2021. [Google Scholar]
  54. Sniehotta, F.F.; Presseau, J.; Araújo-Soares, V. Time to retire the theory of planned behaviour. Health Psychol. Rev. 2014, 8, 1–7. [Google Scholar] [CrossRef]
  55. Muthusamy, G.A.P.; Cheng, K.T.G. The rational—Irrational dialectic with the moderating effect of cognitive bias in the theory of planned behavior. Eur. J. Mol. Clin. Med. 2020, 7, 240–250. [Google Scholar]
  56. Ajzen, I. The theory of planned behaviour is alive and well, and not ready to retire: A commentary on Sniehotta, Presseau, and Araújo-Soares. Health Psychol. Rev. 2015, 9, 131–137. [Google Scholar] [CrossRef]
  57. Bronfenbrenner, U. Toward an experimental ecology of human development. Am. Psychol. 1977, 32, 513–531. [Google Scholar] [CrossRef]
  58. Ullah, A.; Pinglu, C.; Ullah, S.; Abbas, H.S.M.; Khan, S. The Role of E-Governance in Combating COVID-19 and Promoting Sustainable Development: A Comparative Study of China and Pakistan. Chin. Polit. Sci. Rev. 2021, 6, 86–118. [Google Scholar] [CrossRef]
  59. Marrazzo, V. The implementation and use of technologies and big data by local authorities during the COVID-19 pandemic. In Research and Innovation Forum 2021; Springer International Publishing: Cham, Switzerland, 2021. [Google Scholar]
  60. Marten, R.; El-Jardali, F.; Hafeez, A.; Hanefeld, J.; Leung, G.M.; Ghaffar, A. Co-producing the COVID-19 response in Germany, Hong Kong, Lebanon, and Pakistan. BMJ 2021, 372, n243. [Google Scholar] [CrossRef]
  61. Tutsoy, O. COVID-19 Epidemic and Opening of the Schools: Artificial Intelligence-Based Long-Term Adaptive Policy Making to Control the Pandemic Diseases. IEEE Access 2021, 9, 68461–68471. [Google Scholar] [CrossRef]
  62. Maor, M.; Howlett, M. Explaining variations in state COVID-19 responses: Psychological, institutional, and strategic factors in governance and public policy-making. Policy Des. Pract. 2020, 3, 228–241. [Google Scholar] [CrossRef]
  63. Bertozzi, A.L.; Franco, E.; Mohler, G.; Short, M.B.; Sledge, D. The challenges of modeling and forecasting the spread of COVID-19. Proc. Natl. Acad. Sci. USA 2020, 117, 16732–16738. [Google Scholar] [CrossRef]
  64. Jinjarak, Y.; Ahmed, R.; Nair-Desai, S.; Xin, W.; Aizenman, J. Accounting for Global COVID-19 Diffusion Patterns, January–April 2020. Econ. Disasters Clim. Chang. 2020, 4, 515–559. [Google Scholar] [CrossRef]
  65. Adiga, A.; Chen, J.; Marathe, M.; Mortveit, H.; Venkatramanan, S.; Vullikanti, A. Data-driven modeling for different stages of pandemic response. J. Indian. Inst. Sci. 2020, 100, 901–915. [Google Scholar] [CrossRef]
  66. Coston, A.; Guha, N.; Ouyang, D.; Lu, L.; Chouldechova, A.; Ho, D.E. Leveraging administrative data for bias audits: Assessing disparate coverage with mobility data for COVID-19 policy. In Proceedings of the 2021 ACM Conference on Fairness, Accountability, and Transparency, Online, 3–10 March 2021; Association for Computing Machinery: New York, NY, USA, 2021; pp. 173–184. [Google Scholar]
  67. Baker, M.G.; Wilson, N.; Blakely, T. Elimination could be the optimal response strategy for COVID-19 and other emerging pandemic diseases. BMJ 2020, 371, m4907. [Google Scholar] [CrossRef]
  68. Brauner, J.M.; Mindermann, S.; Sharma, M.; Johnston, D.; Salvatier, J.; Gavenčiak, T.; Stephenson, A.B.; Leech, G.; Altman, G.; Mikulik, V.; et al. Inferring the effectiveness of government interventions against COVID-19. Science 2021, 371, eabd9338. [Google Scholar] [CrossRef]
  69. Blasimme, A.; Vayena, E. What’s next for COVID-19 apps? Governance and oversight. Science 2020, 370, 760–762. [Google Scholar] [CrossRef]
  70. Brooks-Pollock, E.; Danon, L.; Jombart, T.; Pellis, L. Modelling that shaped the early COVID-19 pandemic response in the UK. Philos. Trans. R. Soc. B Biol. Sci. 2021, 376, 20210001. [Google Scholar] [CrossRef] [PubMed]
  71. Christensen, T.; Lægreid, P. Balancing Governance Capacity and Legitimacy: How the Norwegian Government Handled the COVID-19 Crisis as a High Performer. Public Adm. Rev. 2020, 80, 774–779. [Google Scholar] [CrossRef]
  72. Duffey, R.B.; Zio, E. COVID-19 Pandemic Trend Modeling and Analysis to Support Resilience Decision-Making. Biology 2020, 9, 156. [Google Scholar] [CrossRef]
  73. Kreuter, F.; Barkay, N.; Bilinski, A.; Bradford, A.; Chiu, S.; Eliat, R.; Fan, J.; Galili, T.; Haimovich, D.; Kim, B.; et al. Partnering with a global platform to inform research and public policy making. Surv. Res. Methods 2020, 14, 159–163. [Google Scholar]
  74. Harrison, T.M.; Pardo, T.A. Data, politics and public health: COVID-19 data-driven decision making in public discourse. Digit. Gov. Res. Pract. 2020, 2, 1–8. [Google Scholar] [CrossRef]
  75. Hasan, A.; Putri, E.; Susanto, H.; Nuraini, N. Data-driven modeling and forecasting of COVID-19 outbreak for public policy making. ISA Trans. 2021. [Google Scholar] [CrossRef]
  76. Lee, S.; Hwang, C.; Moon, M.J. Policy learning and crisis policy-making: Quadruple-loop learning and COVID-19 responses in South Korea. Policy Soc. 2020, 39, 363–381. [Google Scholar] [CrossRef]
  77. Liu, P.; Zhong, X.; Yu, S. Striking a balance between science and politics: Understanding the risk-based policy-making process during the outbreak of COVID-19 epidemic in China. J. Chin. Gov. 2020, 5, 198–212. [Google Scholar] [CrossRef]
  78. Manski, C.F. Forming COVID-19 Policy Under Uncertainty. J. Benefit-Cost Anal. 2020, 11, 341–356. [Google Scholar] [CrossRef]
  79. Ning, Y.; Ren, R.; Nkengurutse, G. China’s model to combat the COVID-19 epidemic: A public health emergency governance approach. Glob. Health Res. Policy 2020, 5, 34. [Google Scholar] [CrossRef] [PubMed]
  80. Panovska-Griffiths, J.; Kerr, C.; Waites, W.; Stuart, R. Mathematical modeling as a tool for policy decision making: Applications to the COVID-19 pandemic. Handb. Stat. 2021, 44, 291–326. [Google Scholar] [CrossRef]
  81. Qiu, R.G.; Wang, E.; Gong, I. Data-Driven Modeling to Facilitate Policymaking in Fighting to Contain the COVID-19 Pandemic. Procedia Comput. Sci. 2021, 185, 320–329. [Google Scholar] [CrossRef]
  82. Sartor, G.; del Riccio, M.; Poz, I.D.; Bonanni, P.; Bonaccorsi, G. COVID-19 in Italy: Considerations on official data. Int. J. Infect. Dis. 2020, 98, 188–190. [Google Scholar] [CrossRef]
  83. Su, Z.; McDonnell, D.; Bentley, B.L.; He, J.; Shi, F.; Cheshmehzangi, A.; Ahmad, J.; Jia, P. Addressing Biodisaster X Threats with Artificial Intelligence and 6G Technologies: Literature Review and Critical Insights. J. Med. Internet Res. 2021, 23, e26109. [Google Scholar] [CrossRef]
  84. Willi, Y.; Nischik, G.; Braunschweiger, D.; Pütz, M. Responding to the COVID-19 Crisis: Transformative Governance in Switzerland. Tijdschr. Econ. Soc. Geogr. 2020, 111, 302–317. [Google Scholar] [CrossRef]
  85. Yu, S.; Qing, Q.; Zhang, C.; Shehzad, A.; Oatley, G.; Xia, F. Data-Driven Decision-Making in COVID-19 Response: A Survey. IEEE Trans. Comput. Soc. Syst. 2021, 8, 1016–1029. [Google Scholar] [CrossRef]
  86. Zawadzki, R.S.; Gong, C.L.; Cho, S.K.; Schnitzer, J.E.; Zawadzki, N.K.; Hay, J.W.; Drabo, E.F. Where Do We Go from Here? A Framework for Using Susceptible-Infectious-Recovered Models for Policy Making in Emerging Infectious Diseases. Value Health 2021, 24, 917–924. [Google Scholar] [CrossRef]
  87. Zheng, Q.; Jones, F.K.; Leavitt, S.V.; Ung, L.; Labrique, A.B.; Peters, D.H.; Lee, E.C.; Azman, A.S.; Adhikari, B.; Wahl, B.; et al. HIT-COVID, a global database tracking public health interventions to COVID-19. Sci. Data 2020, 7, 1–8. [Google Scholar] [CrossRef] [PubMed]
  88. Bayram, M.; Springer, S.; Garvey, C.K.; Özdemir, V. COVID-19 Digital Health Innovation Policy: A Portal to Alternative Futures in the Making. OMICS A J. Integr. Biol. 2020, 24, 460–469. [Google Scholar] [CrossRef]
  89. Feijóo, C.; Kwon, Y.; Bauer, J.M.; Bohlin, E.; Howell, B.; Jain, R.; Potgieter, P.; Vu, K.; Whalley, J.; Xia, J. Harnessing artificial intelligence (AI) to increase wellbeing for all: The case for a new technology diplomacy. Telecommun. Policy 2020, 44, 101988. [Google Scholar] [CrossRef]
  90. Wang, B.; Wen, X. China’s Stringent COVID-19 Control Measures People-Centered, Coordinated Approach. 2021. Available online: https://global.chinadaily.com.cn/a/202108/18/WS611cbd84a310efa1bd6699c5.html (accessed on 12 October 2021).
  91. Institut Économique Molinari. The Zero COVID Strategy Protects People, Economies and Freedoms More Effectively. 2021. Available online: https://www.institutmolinari.org/2021/08/19/the-zero-covid-strategy-protects-people-economies-and-freedoms-more-effectively/ (accessed on 3 October 2021).
  92. Liu, C. China’s ‘Zero Tolerance’ COVID-19 Policy to Safeguard the Country to Withstand Epidemic Flare-Ups Amid Holidays. 2021. [Cited 5 October 2021]. Available online: https://www.globaltimes.cn/page/202109/1234763.shtml (accessed on 5 October 2021).
  93. Zhou, X. China’s Zero COVID Strategy Has the Support of Its People. 2021. Available online: https://asia.nikkei.com/Opinion/China-s-zero-COVID-strategy-has-the-support-of-its-people (accessed on 7 November 2021).
  94. Allam, Z.; Dey, G.; Jones, D.S. Artificial Intelligence (AI) Provided Early Detection of the Coronavirus (COVID-19) in China and Will Influence Future Urban Health Policy Internationally. AI 2020, 1, 156–165. [Google Scholar] [CrossRef] [Green Version]
  95. Syrowatka, A.; Kuznetsova, M.; Alsubai, A.; Beckman, A.L.; Bain, P.A.; Craig, K.J.T.; Hu, J.; Jackson, G.P.; Rhee, K.; Bates, D.W. Leveraging artificial intelligence for pandemic preparedness and response: A scoping review to identify key use cases. NPJ Digit. Med. 2021, 4, 1–14. [Google Scholar] [CrossRef]
  96. Ndiaye, M.; Oyewobi, S.S.; Abu-Mahfouz, A.M.; Hancke, G.P.; Kurien, A.M.; Djouani, K. IoT in the Wake of COVID-19: A Survey on Contributions, Challenges and Evolution. IEEE Access 2020, 8, 186821–186839. [Google Scholar] [CrossRef] [PubMed]
  97. Xiao, H.; Zhou, L.; Liu, L.; Li, X.; Ma, J. Historic opportunity: Artificial intelligence interventions in COVID-19 and other unknown diseases. Acta Biochim. Biophys. Sin. 2021, 53, 1575–1577. [Google Scholar] [CrossRef]
  98. Ghafouri-Fard, S.; Mohammad-Rahimi, H.; Motie, P.; Minabi, M.A.; Taheri, M.; Nateghinia, S. Application of machine learning in the prediction of COVID-19 daily new cases: A scoping review. Heliyon 2021, 7, 08143. [Google Scholar] [CrossRef] [PubMed]
  99. Saxena, N.; Gupta, P.; Raman, R.; Rathore, A.S. Role of data science in managing COVID-19 pandemic. Indian Chem. Eng. 2020, 62, 385–395. [Google Scholar] [CrossRef]
  100. Verma, A.A.; Slutsky, A.S.; Razak, F. The consequences of neglecting to collect multisectoral data to monitor the COVID-19 pandemic. Can. Med. Assoc. J. 2021, 193, E1600. [Google Scholar] [CrossRef]
  101. Hussain, A.; Tahir, A.; Hussain, Z.; Sheikh, Z.; Gogate, M.; Dashtipour, K.; Ali, A.; Sheikh, A. Artificial Intelligence–Enabled Analysis of Public Attitudes on Facebook and Twitter Toward COVID-19 Vaccines in the United Kingdom and the United States: Observational Study. J. Med. Internet Res. 2021, 23, e26627. [Google Scholar] [CrossRef] [PubMed]
  102. Raineri, P.; Molinari, F. Innovation in Data Visualisation for Public Policy Making. In Introduction to Nanotheranostics; Springer: Singapore, 2021; pp. 47–59. [Google Scholar]
  103. Leslie, D.; Mazumder, A.; Peppin, A.; Wolters, M.K.; Hagerty, A. Does “AI” stand for augmenting inequality in the era of COVID-19 healthcare? BMJ 2021, 372, n304. [Google Scholar] [CrossRef] [PubMed]
  104. Griglio, E. Parliamentary oversight under the COVID-19 emergency: Striving against executive dominance. Theory Pract. Legis. 2020, 8, 49–70. [Google Scholar] [CrossRef]
  105. Bolleyer, N.; Salát, O. Parliaments in times of crisis: COVID-19, populism and executive dominance. West Eur. Politi. 2021, 44, 1103–1128. [Google Scholar] [CrossRef]
  106. Cave, S.; Whittlestone, J.; Nyrup, R.; Heigeartaigh, S.O.; Calvo, R.A. Using AI ethically to tackle covid-19. BMJ 2021, 372, n364. [Google Scholar] [CrossRef]
  107. Krass, M.; Henderson, P.; Mello, M.M.; Studdert, D.M.; Ho, D.E. How US law will evaluate artificial intelligence for COVID-19. BMJ 2021, 372, n234. [Google Scholar] [CrossRef]
  108. Carrapico, H.; Farrand, B. Discursive continuity and change in the time of COVID-19: The case of EU cybersecurity policy. J. Eur. Integr. 2020, 42, 1111–1126. [Google Scholar] [CrossRef]
  109. Su, Z.; McDonnell, D.; Li, X.; Bennett, B.; Šegalo, S.; Abbas, J.; Cheshmehzangi, A.; Xiang, Y.-T. COVID-19 Vaccine Donations—Vaccine Empathy or Vaccine Diplomacy? A Narrative Literature Review. Vaccines 2021, 9, 1024. [Google Scholar] [CrossRef] [PubMed]
  110. Barberia, L.G.; Gómez, E.J. Political and institutional perils of Brazil’s COVID-19 crisis. Lancet 2020, 396, 367–368. [Google Scholar] [CrossRef]
  111. Chernozhukov, V.; Kasahara, H.; Schrimpf, P. Causal impact of masks, policies, behavior on early COVID-19 pandemic in the U.S. J. Econ. 2021, 220, 23–62. [Google Scholar] [CrossRef]
  112. Bodas, M.; Peleg, K. Self-isolation compliance in the COVID-19 era influenced by compensation: Findings from a recent survey in Israel. Health Aff. 2020, 39, 936–941. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Lin, Q.; Zhao, S.; Gao, D.; Lou, Y.; Yang, S.; Musa, S.S.; Wang, M.H.; Cai, Y.; Wang, W.; Yang, L.; et al. A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action. Int. J. Infect. Dis. 2020, 93, 211–216. [Google Scholar] [CrossRef]
  114. Brzezinski, A.; Kecht, V.; van Dijcke, D.; Wright, A.L. Belief in Science Influences Physical Distancing in Response to COVID-19 Lockdown Policies; Becker Friedman Institute for Economics Working Paper (2020-56); University of Chicago: Chicago, IL, USA, 2020. [Google Scholar]
  115. Wright, A.L.; Sonin, K.; Driscoll, J.; Wilson, J. Poverty and economic dislocation reduce compliance with COVID-19 shelter-in-place protocols. J. Econ. Behav. Organ. 2020, 180, 544–554. [Google Scholar] [CrossRef]
  116. Swami, V.; Barron, D. Analytic Thinking, Rejection of Coronavirus (COVID-19) Conspiracy Theories, and Compliance with Mandated Social-Distancing: Direct and Indirect Relationships in a Nationally Representative Sample of Adults in the United Kingdom. 2020. Available online: https://journals.sagepub.com/doi/full/10.1177/18344909211037385 (accessed on 24 November 2021).
  117. Briscese, G.; Lacetera, N.; Macis, M.; Tonin, M. Compliance with COVID-19 Social-Distancing Measures in Italy: The Role of Expectations and Duration; National Bureau of Economic Research: Cambridge, MA, USA, 2020. [Google Scholar]
  118. The Economist. How Long Can China’s Zero-COVID Policy Last? 2021. Available online: https://www.economist.com/china/2021/10/16/how-long-can-chinas-zero-covid-policy-last (accessed on 16 October 2021).
  119. Willis, S. Singapore Is Trying to Do what No Other Country Has Done: Pivot Away from COVID-Zero. Will It Work? 2021. Available online: https://fortune.com/2021/08/24/singapore-pivot-covid-zero-reopening-international-travel/ (accessed on 7 October 2021).
  120. Menon, P. New Zealand Drops COVID-19 Elimination Strategy under Pressure from Delta. 2021. Available online: https://www.reuters.com/world/asia-pacific/new-zealand-extends-auckland-lockdown-eases-some-curbs-2021-10-04/ (accessed on 7 October 2021).
  121. Oliu-Barton, M.; Pradelski, B.S.R.; Aghion, P.; Artus, P.; Kickbusch, I.; Lazarus, J.V.; Sridhar, D.; Vanderslott, S. SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties. Lancet 2021, 397, 2234–2236. [Google Scholar] [CrossRef]
  122. Helliwell, J.; Norton, M.; Wang, S.; Aknin, L.; Huang, H. Well-Being Analysis Favours a Virus-Elimination Strategy for COVID-19; National Bureau of Economic Research: Cambridge, MA, USA, 2021. [Google Scholar] [CrossRef]
  123. Wang, V. Why China Is the World’s Last ‘Zero COVID’ Holdout 2021. Available online: https://www.nytimes.com/2021/10/27/world/asia/china-zero-covid-virus.html (accessed on 30 October 2021).
  124. Su, Z.; Liang, B.; Shi, F.; Gelfond, J.; Šegalo, S.; Wang, J.; Jia, P.; Hao, X. Deep learning-based facial image analysis in medical research: A systematic review protocol. BMJ Open 2021, 11, e047549. [Google Scholar] [CrossRef] [PubMed]
  125. Alimadadi, A.; Aryal, S.; Manandhar, I.; Munroe, P.B.; Joe, B.; Cheng, X. Artificial intelligence and machine learning to fight COVID-19. Physiol. Genom. 2020, 52, 200–202. [Google Scholar] [CrossRef]
  126. Naudé, W. Artificial intelligence vs COVID-19: Limitations, constraints and pitfalls. AI Soc. 2020, 35, 761–765. [Google Scholar] [CrossRef]
  127. Bullock, J.; Luccioni, A.; Pham, K.H.; Lam, C.S.N.; Luengo-Oroz, M. Mapping the landscape of Artificial Intelligence applications against COVID-19. J. Artif. Intell. Res. 2020, 69, 807–845. [Google Scholar] [CrossRef]
  128. Saad, W.; Bennis, M.; Chen, M. A Vision of 6G Wireless Systems: Applications, Trends, Technologies, and Open Research Problems. IEEE Netw. 2019, 34, 134–142. [Google Scholar] [CrossRef] [Green Version]
  129. Samsung Research, 6G: The Next Hyper Connected Experience for All Samsung Research, Editor. 2020. Available online: https://cdn.codeground.org/nsr/downloads/researchareas/20201201_6G_Vision_web.pdf (accessed on 24 November 2021).
  130. Zhou, Y.; Liu, L.; Wang, L.; Hui, N.; Cui, X.; Wu, J.; Peng, Y.; Qi, Y.; Xing, C. Service-aware 6G: An intelligent and open network based on the convergence of communication, computing and caching. Digit. Commun. Netw. 2020, 6, 253–260. [Google Scholar] [CrossRef]
  131. Nawaz, F.; Ibrahim, J.; Awais, M.; Junaid, M.; Kousar, S.; Parveen, T. A Review of Vision and Challenges of 6G Technology. Int. J. Adv. Comput. Sci. Appl. 2020, 11, 11. [Google Scholar] [CrossRef] [Green Version]
  132. Alsharif, M.H.; Kelechi, A.H.; Albreem, M.A.; Chaudhry, S.A.; Zia, M.S.; Kim, S. Sixth Generation (6G) Wireless Networks: Vision, Research Activities, Challenges and Potential Solutions. Symmetry 2020, 12, 676. [Google Scholar] [CrossRef]
  133. Dang, S.; Amin, O.; Shihada, B.; Alouini, M.S. What should 6G be? Nat. Electron. 2020, 3, 20–29. [Google Scholar] [CrossRef] [Green Version]
  134. Chowdhury, M.Z.; Shahjalal, M.; Ahmed, S.; Jang, Y.M. 6G Wireless Communication Systems: Applications, Requirements, Technologies, Challenges, and Research Directions. IEEE Open J. Commun. Soc. 2020, 1, 957–975. [Google Scholar] [CrossRef]
  135. Letaief, K.B.; Chen, W.; Shi, Y.; Zhang, J.; Zhang, Y.-J.A. The Roadmap to 6G: AI Empowered Wireless Networks. IEEE Commun. Mag. 2019, 57, 84–90. [Google Scholar] [CrossRef] [Green Version]
  136. Ding, H.; Zhang, J. Social media and participatory risk communication during the H1N1 flu epidemic: A comparative study of the United States and China. China Media Res. 2010, 6, 80–91. [Google Scholar]
  137. Chen, E.; Lerman, K.; Ferrara, E. Tracking Social Media Discourse About the COVID-19 Pandemic: Development of a Public Coronavirus Twitter Data Set. JMIR Public Health Surveill. 2020, 6, e19273. [Google Scholar] [CrossRef]
  138. Gao, Z.; Yada, S.; Wakamiya, S.; Aramaki, E. Naist COVID: Multilingual COVID-19 twitter and weibo dataset. arXiv 2020, arXiv:2004.08145. [Google Scholar]
  139. Gao, X.; Lee, J. E-government services and social media adoption: Experience of small local governments in Nebraska state. Gov. Inf. Q. 2017, 34, 627–634. [Google Scholar] [CrossRef]
  140. Ristevski, B.; Chen, M. Big Data Analytics in Medicine and Healthcare. J. Integr. Bioinform. 2018, 15. [Google Scholar] [CrossRef]
  141. Rowe, G.; Frewer, L.J. A Typology of Public Engagement Mechanisms. Sci. Technol. Hum. Values 2005, 30, 251–290. [Google Scholar] [CrossRef]
  142. Wallach, W. Robot minds and human ethics: The need for a comprehensive model of moral decision making. Ethic. Inf. Technol. 2010, 12, 243–250. [Google Scholar] [CrossRef]
  143. Nath, R.; Sahu, V. The problem of machine ethics in artificial intelligence. AI Soc. 2017, 35, 103–111. [Google Scholar] [CrossRef]
  144. Hildt, E. Artificial Intelligence: Does Consciousness Matter? Front. Psychol. 2019, 10, 1535. [Google Scholar] [CrossRef]
  145. Meissner, G. Artificial intelligence: Consciousness and conscience. AI Soc. 2019, 35, 225–235. [Google Scholar] [CrossRef]
  146. Cihon, P.; Maas, M.M.; Kemp, L. Should artificial intelligence governance be centralised? Design lessons from history. In Proceedings of the AAAI/ACM Conference on AI, Ethics, and Society, Online, 19–21 May 2021; Association for Computing Machinery: New York, NY, USA, 2021; pp. 228–234. [Google Scholar]
  147. Li, J.; Guo, K.; Viedma, E.H.; Lee, H.; Liu, J.; Zhong, N.; Gomes, L.F.A.M.; Filip, F.G.; Fang, S.-C.; Özdemir, M.S.; et al. Culture versus Policy: More Global Collaboration to Effectively Combat COVID-19. Innovation 2020, 1, 100023. [Google Scholar] [CrossRef]
  148. De Zwart, F. Unintended but not unanticipated consequences. Theory Soc. 2015, 44, 283–297. [Google Scholar] [CrossRef] [Green Version]
  149. Sober, E. The Principle of Parsimony. Br. J. Philos. Sci. 1981, 32, 145–156. [Google Scholar] [CrossRef]
  150. Richards, T.; Scowcroft, H. Patient and public involvement in COVID-19 policy making. BMJ 2020, 370, m2575. [Google Scholar] [CrossRef]
  151. Matzopoulos, R.; Walls, H.; Cook, S.; London, L. South Africa’s COVID-19 Alcohol Sales Ban: The Potential for Better Policy-Making. Int. J. Health Policy Manag. 2020, 9, 486–487. [Google Scholar] [CrossRef]
  152. Rangel, J.C.; Ranade, S.; Sutcliffe, P.; Mykhalovskiy, E.; Gastaldo, D.; Eakin, J. COVID-19 policy measures—Advocating for the inclusion of the social determinants of health in modelling and decision making. J. Eval. Clin. Pract. 2020, 26, 1078–1080. [Google Scholar] [CrossRef]
  153. Graeden, E.; Carlson, C.; Katz, R. Answering the right questions for policymakers on COVID-19. Lancet Glob. Health 2020, 8, e768–e769. [Google Scholar] [CrossRef]
  154. Cohen, J.; Kupferschmidt, K. Countries test tactics in ‘war’ against COVID-19. Science 2020, 367, 1287. [Google Scholar] [CrossRef] [Green Version]
  155. Dye, T.R. Understanding Public Policy; Prentice-Hall: Englewood Cliffs, NJ, USA, 1972. [Google Scholar]
  156. Voinov, A.; Kolagani, N.; McCall, M.K.; Glynn, P.D.; Kragt, M.E.; Ostermann, F.O.; Pierce, S.A.; Ramu, P. Modelling with stakeholders—Next generation. Environ. Model. Softw. 2016, 77, 196–220. [Google Scholar] [CrossRef]
  157. Mitton, C.; Smith, N.; Peacock, S.; Evoy, B.; Abelson, J. Public participation in health care priority setting: A scoping review. Health Policy 2009, 91, 219–228. [Google Scholar] [CrossRef]
  158. Bobbio, L. Designing effective public participation. Policy Soc. 2018, 38, 41–57. [Google Scholar] [CrossRef] [Green Version]
  159. Shiller, J.T. Preparing for democracy: How community-based organizations build civic engagement among urban youth. Urban Educ. 2012, 48, 69–91. [Google Scholar] [CrossRef]
Figure 1. A schematic representation of noncollaborative and collaborative policy-making processes.
Figure 1. A schematic representation of noncollaborative and collaborative policy-making processes.
Ijerph 18 12447 g001
Figure 2. An example utilization of the PADS model in the context of aging-in-place policies.
Figure 2. An example utilization of the PADS model in the context of aging-in-place policies.
Ijerph 18 12447 g002
Table 1. Example PubMed search strings.
Table 1. Example PubMed search strings.
ConceptSearch Strings
Policy making“policy making” [MeSH] OR “policy making” [TIAB] OR “policy-making” [MeSH] OR “policy-making” [TIAB] OR “policy” [MeSH] OR “policy” [TIAB] OR “policies” [TIAB]
COVID-19((coronavirus OR “corona virus” OR coronavirinae OR coronaviridae OR betacoronavirus OR covid19 OR “covid 19” OR nCoV OR “CoV 2” OR CoV2 OR sarscov2 OR 2019nCoV OR “novel CoV” OR “wuhan virus”) OR ((wuhan OR hubei OR huanan) AND (“severe acute respiratory” OR pneumonia) AND (outbreak)) OR “Coronavirus” [Mesh] OR “Coronavirus Infections” [Mesh] OR “COVID-19” [Supplementary Concept] OR “severe acute respiratory syndrome coronavirus 2” [Supplementary Concept] OR “Betacoronavirus” [Mesh])
Table 2. List of articles included in the final review.
Table 2. List of articles included in the final review.
AuthorYearTitle
Adiga et al. [65]2020Data-driven modeling for different stages of pandemic response
Amanda et al. [66]2021Leveraging administrative data for bias audits: Assessing disparate coverage with mobility data for COVID-19 policy
Baker et al. [67]2020Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases
Baruner Jan et al. [68]2021Inferring the effectiveness of government interventions against COVID-19
Bertozzi et al. [63]2020The challenges of modeling and forecasting the spread of COVID-19
Blasimme et al. [69]2020What’s next for COVID-19 apps? Governance and oversight
Brooks-Pollock et al. [70]2021Modelling that shaped the early COVID-19 pandemic response in the UK
Christensen et al. [71]2020Balancing governance capacity and legitimacy: How the Norwegian government handled the COVID-19 crisis as a high performer
Duffey et al. [72]2020COVID-19 pandemic trend modeling and analysis to support resilience decision-making
Frauke et al. [73]2020Partnering with a global platform to inform research and public policy making
Harrison et al. [74]2020Data, politics and public health: COVID-19 data-driven decision making in public discourse
Hasan et al. [75]2021Data-driven modeling and forecasting of COVID-19 outbreak for public policy making
Lee et al. [76]2020Policy learning and crisis policy-making: quadruple-loop learning and COVID-19 responses in South Korea
Liu et al. [77]2020Striking a balance between science and politics: understanding the risk-based policy-making process during the outbreak of COVID-19 epidemic in China
Manski [78]2020Forming COVID-19 policy under uncertainty
Maor et al. [62]2020Explaining variations in state COVID-19 responses: psychological, institutional, and strategic factors in governance and public policy-making
Mazey et al. [47]2020Lesson-drawing from New Zealand and COVID-19: the need for anticipatory policy making
Ning et al. [79]2020China’s model to combat the COVID-19 epidemic: a public health emergency governance approach
Panovska-Griffiths et al. [80]2021Mathematical modeling as a tool for policy decision making: Applications to the COVID-19 pandemic
Qiu et al. [81]2021Data-driven modeling to facilitate policymaking in fighting to contain the COVID-19 pandemic
Sartor et al. [82]2020COVID-19 in Italy: Considerations on official data
Su et al. [83]2020Addressing Biodisaster X threats with artificial intelligence and 6G technologies: Literature review and critical insights
Totsoy [61]2021COVID-19 epidemic and opening of the schools: artificial intelligence-based long-term adaptive policy making to control the pandemic diseases
Ullah et al. [58]2021The role of e-governance in combating COVID-19 and promoting sustainable development: A comparative study of China and Pakistan
Willi et al. [84]2020Responding to the COVID-19 crisis: Transformative governance in Switzerland
Yu et al. [85]2021Data-driven decision-making in COVID-19 response: A survey
Zawadzki et al. [86]2021Where do we go from here? A framework for using susceptible-infectious-recovered models for policy making in emerging infectious diseases
Zheng et al. [87]2020HIT-COVID, a global database tracking public health interventions to COVID-19
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Su, Z. Rigorous Policy-Making Amid COVID-19 and Beyond: Literature Review and Critical Insights. Int. J. Environ. Res. Public Health 2021, 18, 12447. https://doi.org/10.3390/ijerph182312447

AMA Style

Su Z. Rigorous Policy-Making Amid COVID-19 and Beyond: Literature Review and Critical Insights. International Journal of Environmental Research and Public Health. 2021; 18(23):12447. https://doi.org/10.3390/ijerph182312447

Chicago/Turabian Style

Su, Zhaohui. 2021. "Rigorous Policy-Making Amid COVID-19 and Beyond: Literature Review and Critical Insights" International Journal of Environmental Research and Public Health 18, no. 23: 12447. https://doi.org/10.3390/ijerph182312447

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop